藥物篩選&開發(fā)技術(shù)論壇 DSDT 2015將在上海召開

瀏覽次數(shù)：5979　發(fā)布日期：2014-9-28　來源：本站　本站原創(chuàng)，轉(zhuǎn)載請(qǐng)注明出處

Drug Screening and Discovery Technologies Asian Forum 2015

Jan.21 (Wednesday) to Jan.22 (Thursday).2015

InterContinental Shanghai Pudong Hotel

Produced by: Deliver Consulting Limited

Supported by: Society for Laboratory Automation and Screening

Program Overview

The ‘Drug Screening and Discovery Technologies Asian Forum 2015’ is the annual forum produced by Deliver Consulting, exclusively focusing on the Asian concurrent screening and discovery technologies and innovation and is aiming to construct efficient dialogues for the improved scientific communication, partnership and is expecting invite over 35 keynote speakers and 200 senior scientists, Chief/Principal Investigators, R&D executives on target identification and validation; assay development and screening, library strategies and management, hit-to-lead exploration and early safety and efficacy assessment.

Program Key Discussions

► Target-based and Phenotypic Screening and Drug Discovery

► Functional Genomics and High Content Screening

► Natural Products Screening and Chemistry

► Screening Library Strategies, Virtual Screening and Library Management

► Novel Discovery Techniques and Assay Models

Confirmed Keynote Speakers

▪ Prof. Ming-Wei Wang, Director, The National Center for Drug Screening, CAS

▪ Prof. Li-Xin Zhang, Deputy Director, CAS Key Laboratory of Pathogenic Microbiology & Immunology; Inaugural Director for Drug Discovery Center for TB, Institute of Microbiology, CAS

▪ Prof. Baoxue Yang, Chair, Department of Pharmacology, School of Basic Medical Sciences, Peking University

▪ Prof. Wensheng Wei, Principal Investigator, College of Life Sciences, Peking University

▪ Prof. Lili Wang, Pharmacology Professor, Beijing Institute of Pharmacology and Toxicology

▪ Prof. Xulin Chen, Director, Antiviral Research Group, State Key Laboratory of Virology, Wuhan Institute of Virology, CAS

▪ Prof. Qing-Song Liu, Principal Investigator, Vice Director, Life Science Dept. High Magnetic Field Laboratory, CAS

▪ Prof. Jonathan Baell, Professor, MIPS, Monash University

▪ Prof. Hiroyuki Osada, Group Director, Chemical Biology Group, Deputy Director, Riken Center for Sustainable Resource Science

▪ Prof. Thomas Dick, Head, Antibacterial Drug Discovery Laboratory, The National University of Singapore

▪ Dr. Kurt Lackovic, Business and HTS Development Manager, The Walter + Eliza Hall Institute of Medical Research

▪ Prof. Ho-Jeong Kwon, Chairman, Dept. of Biotechnology, Yonsei University

▪ Prof. Seung-Bum Park, Director for Chemical Proteomics, Seoul National University

▪ Prof. Joon-Myong Song, Chair, Department of Pharmacy, Seoul National Unversity

▪ Dr. Kanury Rao, Head, Drug Discovery Research Centre, THSTI, Ministry of Science and Technology, Govt. of India

▪ Dr. Marc Bickle, Head, HT-Technology Development Studio, Max Planck Institute of Molecular Cell Biology and Genetics, Germany

▪ Dr. Zhiyuan Zhang, Director, Translational Research Center, NIBS

▪ Dr. Giridharan Periyasamy, Head, Centre for High Throughput Phenomics, Genome Institute of Singapore

▪ Prof. Meng-Ru Shen, Associate Dean for Research, Chair of Pharmacology, National Cheng Kung University

Please click here to review the up-to-date speaker panel and research focus.

Who Should Attend

Approx. 200 senior scientists, Chief/Principal Investigators, R&D executives are expected to attend 'Drug Screening and Discovery Technologies Asian Forum 2015', attracting a strong contingent throughout Asia Pacific, US and EU. The participants will mainly come from academia, research institutes, pharmaceutical and biotechnology companies and hospitals with the main responsibilities including but not limited to:

▪ Target Identification and Validation	▪ Preclinical Development
▪ Assay Development	▪ ADME
▪ Laboratory Automation	▪ Medicinal Chemistry
▪ Compound Profiling	▪ Chemical Biology
▪ High Content Analysis	▪ Chemical Genomics
▪ Cell Biology	▪ Chemical Genetics
▪ Natural Products Research	▪ Biochemical/Cellular Assay
▪ Stem Cell Research	▪ Functional Genomics
▪ Lead Generation	▪ Compound Management

Joining as a Delegate

Currently conference registration is available. Register before Nov.25. 2014, you will receive the reduced rate at CNY 5,000 / USD 820 for commercial organizations and CNY 3,500 / USD 575 for academia. Corporate will also enjoy considerable discounts by sending team to this conference.

Exhibiting and Supporting Opportunities

Exhibiting and supporting this screening forum is an effective measure to promote and reinforce your latest findings, cutting-edge products and services to a highly targeted group of key decision makers, scientists and end-users who are aiming to improve their assay development, screening and drug discovery productivity. These marketing and industry supporting opportunities also help committee to underwrite the cost of a service, program or incentive that we provide to conference attendees. Therefore, in addition to the branding recognition that you will receive, the committee also provides extra benefits to show our gratitude to those organizations of certain support levels.

Presenting a Poster

All attendees are encouraged to present a poster on the blackboard at site. The specification is A3 297 *420 mm, colorful with high resolution. All posters shall be printed out and carried by the registered organization.

For more information and enquiries about the latest forum agenda and speaking arrangement; attending, exhibiting and supporting options, please contact with:

Wei Zhang

Project Manager

86.21.6034.0229

wzhang@deliver-consulting.com

參會(huì)咨詢

【點(diǎn)擊查看其它會(huì)展信息】

分享到：QQ空間新浪微博騰訊微博微信